Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma

No effective systemic chemotherapy is well-established in basal cell carcinoma. We report a case with three simultaneous malignancies: colon cancer, basal cell carcinoma, and smoldering multiple myeloma. The patient was treated with capecitabine and oxaliplatin after surgery for colon cancer. Surpri...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Jiyoung, Jo, Jaemin, Han, Sang-Hoon, Kwon, Jung-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992662/
https://www.ncbi.nlm.nih.gov/pubmed/33911569
http://dx.doi.org/10.5021/ad.2019.31.2.201
_version_ 1783669422855028736
author Rhee, Jiyoung
Jo, Jaemin
Han, Sang-Hoon
Kwon, Jung-Mi
author_facet Rhee, Jiyoung
Jo, Jaemin
Han, Sang-Hoon
Kwon, Jung-Mi
author_sort Rhee, Jiyoung
collection PubMed
description No effective systemic chemotherapy is well-established in basal cell carcinoma. We report a case with three simultaneous malignancies: colon cancer, basal cell carcinoma, and smoldering multiple myeloma. The patient was treated with capecitabine and oxaliplatin after surgery for colon cancer. Surprisingly, he achieved a complete response for basal cell carcinoma. This is the first report of this chemotherapy regimen in basal cell carcinoma. This finding suggests that combination capecitabine and oxaliplatin can be a treatment option for patients unable to receive local therapy.
format Online
Article
Text
id pubmed-7992662
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-79926622021-04-27 Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma Rhee, Jiyoung Jo, Jaemin Han, Sang-Hoon Kwon, Jung-Mi Ann Dermatol Case Report No effective systemic chemotherapy is well-established in basal cell carcinoma. We report a case with three simultaneous malignancies: colon cancer, basal cell carcinoma, and smoldering multiple myeloma. The patient was treated with capecitabine and oxaliplatin after surgery for colon cancer. Surprisingly, he achieved a complete response for basal cell carcinoma. This is the first report of this chemotherapy regimen in basal cell carcinoma. This finding suggests that combination capecitabine and oxaliplatin can be a treatment option for patients unable to receive local therapy. The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2019-04 2019-02-28 /pmc/articles/PMC7992662/ /pubmed/33911569 http://dx.doi.org/10.5021/ad.2019.31.2.201 Text en Copyright © 2019 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rhee, Jiyoung
Jo, Jaemin
Han, Sang-Hoon
Kwon, Jung-Mi
Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
title Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
title_full Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
title_fullStr Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
title_full_unstemmed Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
title_short Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
title_sort capecitabine plus oxaliplatin combination therapy for basal cell carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992662/
https://www.ncbi.nlm.nih.gov/pubmed/33911569
http://dx.doi.org/10.5021/ad.2019.31.2.201
work_keys_str_mv AT rheejiyoung capecitabineplusoxaliplatincombinationtherapyforbasalcellcarcinoma
AT jojaemin capecitabineplusoxaliplatincombinationtherapyforbasalcellcarcinoma
AT hansanghoon capecitabineplusoxaliplatincombinationtherapyforbasalcellcarcinoma
AT kwonjungmi capecitabineplusoxaliplatincombinationtherapyforbasalcellcarcinoma

Ejemplares similares